Literature DB >> 20617568

Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo.

Yoshitaka Ito1, Kenta Ito, Takashi Shiroto, Ryuji Tsuburaya, Gao Jun Yi, Morihiko Takeda, Yoshihiro Fukumoto, Satoshi Yasuda, Hiroaki Shimokawa.   

Abstract

OBJECTIVES: Left ventricular (LV) remodeling after acute myocardial infarction (AMI) is associated with a poor prognosis and an impaired quality of life. We have shown earlier that low-energy extracorporeal cardiac shock wave (SW) therapy improves chronic myocardial ischemia in pigs and humans and also ameliorates LV remodeling in a pig model of AMI induced by permanent coronary ligation. However, in the current clinical setting, most of the patients with AMI receive reperfusion therapy. Thus, in this study we examined whether our SW therapy also ameliorates LV remodeling after myocardial ischemia-reperfusion (I/R) injury in pigs in vivo.
METHODS: Pigs were subjected to a 90-min ischemia and reperfusion using a balloon catheter and were randomly assigned to two groups with or without SW therapy to the ischemic border zone (0.09 mJ/mm(2), 200 pulses/spot, 9 spots/animal, three times in the first week) (n = 15 each).
RESULTS: Four weeks after I/R, compared with the control group, the SW group showed significantly ameliorated LV remodeling in terms of LV enlargement (131 +/- 9 vs. 100 +/- 7 ml), reduced LV ejection fraction (28 +/- 2 vs. 36 +/- 3%), and elevated left ventricular end-diastolic pressure (11 +/- 2 vs. 4 +/- 1 mmHg) (all P <0.05, n = 8 each). The SW group also showed significantly increased regional myocardial blood flow (-0.06 +/- 0.11 vs. 0.36 +/- 0.13 ml/min/g, P < 0.05), capillary density (1.233 +/- 31 vs. 1.560 +/- 60/mm(2), P < 0.001), and endothelial nitric oxide synthase activity (0.24 +/- 0.03 vs. 0.41 +/- 0.05, P < 0.05) in the ischemic border zone compared with the control group (n = 7 each).
CONCLUSION: These results indicate that our SW therapy is also effective in ameliorating LV remodeling after myocardial I/R injury in pigs in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617568     DOI: 10.1097/mca.0b013e32833aec62

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  23 in total

Review 1.  Extracorporeal shock wave therapy mechanisms in musculoskeletal regenerative medicine.

Authors:  Claudio Lopes Simplicio; Joseph Purita; William Murrell; Gabriel Silva Santos; Rafael Gonzales Dos Santos; José Fábio Santos Duarte Lana
Journal:  J Clin Orthop Trauma       Date:  2020-02-12

2.  Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study.

Authors:  Na Jia; Ruisheng Zhang; Baoyi Liu; Bing Liu; Xin Qi; Ming Lan; Junmeng Liu; Ping Zeng; Congxia Chen; Wenchan Li; Yue Guo; Zhiming Yao; Qing He
Journal:  J Nucl Cardiol       Date:  2021-09-02       Impact factor: 3.872

Review 3.  Cardiovascular applications of therapeutic ultrasound.

Authors:  Babak Nazer; Edward P Gerstenfeld; Akiko Hata; Lawrence A Crum; Thomas J Matula
Journal:  J Interv Card Electrophysiol       Date:  2013-12-03       Impact factor: 1.900

4.  Shockwave treatment of erectile dysfunction.

Authors:  Ilan Gruenwald; Boaz Appel; Noam D Kitrey; Yoram Vardi
Journal:  Ther Adv Urol       Date:  2013-04

5.  Cardiac shockwave therapy improves myocardial function in patients with refractory coronary artery disease by promoting VEGF and IL-8 secretion to mediate the proliferation of endothelial progenitor cells.

Authors:  Hong-Yan Cai; Lin Li; Tao Guo; Y U Wang; Tie-Kun Ma; Jian-Ming Xiao; Ling Zhao; Yin Fang; Ping Yang; H U Zhao
Journal:  Exp Ther Med       Date:  2015-10-20       Impact factor: 2.447

Review 6.  ESWT for tendinopathy: technology and clinical implications.

Authors:  Henk van der Worp; Inge van den Akker-Scheek; Hans van Schie; Johannes Zwerver
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-05-01       Impact factor: 4.342

7.  Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment.

Authors:  Morgan Fu; Cheuk-Kwan Sun; Yu-Chun Lin; Ching-Jen Wang; Chiung-Jen Wu; Sheung-Fat Ko; Sarah Chua; Jiunn-Jye Sheu; Chiang-Hua Chiang; Pei-Lin Shao; Steve Leu; Hon-Kan Yip
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

Review 8.  Penile low-intensity shock wave therapy: a promising novel modality for erectile dysfunction.

Authors:  Yasmin Abu-Ghanem; Noam D Kitrey; Ilan Gruenwald; Boaz Appel; Yoram Vardi
Journal:  Korean J Urol       Date:  2014-05-12

9.  Low-intensity pulsed ultrasound induces angiogenesis and ameliorates left ventricular dysfunction in a porcine model of chronic myocardial ischemia.

Authors:  Kenichiro Hanawa; Kenta Ito; Kentaro Aizawa; Tomohiko Shindo; Kensuke Nishimiya; Yuhi Hasebe; Ryuji Tuburaya; Hideyuki Hasegawa; Satoshi Yasuda; Hiroshi Kanai; Hiroaki Shimokawa
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

10.  The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model.

Authors:  Chun-Li Song; Bin Liu; Hong-Ying Diao; Yong-Feng Shi; Yang-Xue Li; Ji-Chang Zhang; Yang Lu; Guan Wang; Jia Liu; Yun-Peng Yu; Zi-Yuan Guo; Jin-Peng Wang; Zhuo Zhao; Jian-Gen Liu; Yi-Hang Liu; Zhi-Xian Liu; Dan Cai; Qian Li
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.